Literature DB >> 17413408

Thyroid cancer invasion of neck structures: epidemiology, evaluation, staging and management.

Randall P Morton1, Zahoor Ahmad.   

Abstract

PURPOSE OF REVIEW: This review addresses the issue of direct extra-capsular invasion of thyroid cancer; this may occur in several ways and to varying degrees. The evidence regarding the prognostic and treatment implications of extra-thyroidal spread is examined. The phenomenon is most common in papillary carcinoma of the thyroid and that is the focus for this review. Less common, but more aggressive tumours (medullary and anaplastic carcinoma) are not considered here. RECENT
FINDINGS: Overall, around 15% of thyroid cancers exhibit extra-thyroid spread but the rate is much higher in specific subgroups. The presence of invasive disease affects the staging of the tumour, and the implications for surgery can be substantial if complete tumour extirpation is to be achieved. No particular examination is completely accurate in detecting extra-thyroid spread preoperatively. Invasion posteriorly carries greater morbidity and mortality than anterior spread. The presence of extra-thyroid spread usually warrants adjuvant radiotherapy (radioiodine or external beam).
SUMMARY: Histologic assessment is the gold standard for detecting invasive thyroid cancer. Thyroidectomy is effectively a staging procedure by which the presence and extent of invasive disease can be established and subsequent management determined. Extra-thyroidal spread influences morbidity and mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17413408     DOI: 10.1097/MOO.0b013e3280147348

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  6 in total

1.  Fungating thyroid cancer: a complex clinical scenario.

Authors:  A S Nabawi; H F Al Wagih; M A Hemeida; T Y Koraitim; M Moussa; Tarek Ezzat
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Metastasis of papillary thyroid cancer to the larynx and pharynx: unusual case report.

Authors:  Arsheed H Hakeem; Sultan A Pradhan; Sanica Bhele; Jagadish Tubachi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-15       Impact factor: 2.503

3.  Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.

Authors:  Daisy V Alapat; Kenneth B Ain; David A Sloan; Kristin G Monaghan; Rouzan G Karabakhtsian
Journal:  Endocrine       Date:  2011-01-18       Impact factor: 3.633

4.  Brachial plexus compression: a rare sequelae of malignant papillary thyroid carcinoma.

Authors:  Amit S Patel; John M Carter; Paul L Friedlander; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2013-08-01

5.  COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study.

Authors:  Nikhita Kathuria-Prakash; Tina Mosaferi; Mindy Xie; Lauren Antrim; Trevor E Angell; Gino K In; Maureen A Su; Melissa G Lechner
Journal:  Endocr Pract       Date:  2021-01-04       Impact factor: 3.443

6.  Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension.

Authors:  Manuel Weber; Ina Binse; Karin Oebbecke; Tim Brandenburg; Ken Herrmann; Sarah Theurer; Frank Weber; Ann-Kathrin Ehrlich; Kurt Werner Schmid; Dagmar Führer-Sakel; Irfan Vardarli; Wolfgang P Fendler; Elena Gilman; Rainer Görges
Journal:  BMC Endocr Disord       Date:  2021-08-10       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.